Annual EBITDA
$167.85M$57.90M+52.67%
Summary
- Current Value
- As of today, KRYS annual EBITDA is $167.85M, up +52.67% on
- Historical Performance
- KRYS annual EBITDA is up +244.52% over the past 3 years, up +638.87% over the past 5 years
- All-Time High Comparison
- KRYS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- KRYS annual EBITDA is +244.52% above its 3-year low of -$116.14M reached on an earlier date
- Sector Comparison
- KRYS annual EBITDA is higher than 85.76% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $167.85M | +52.7% | +244.5% | +638.9% | +10000.0% | |
| Quarterly EBITDA | $55.42M | +46.6% | +257.3% | +501.1% | +100.0% | |
| TTM EBITDA | $185.28M | +32.1% | +245.7% | +568.0% | +100.0% | |
| Price | $324.77 | +140.7% | +161.5% | +473.2% | – | |
| PE Ratio | 43.41 | +58.1% | – | – | – | |
| Annual Revenue | $389.13M | +33.9% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | $6.84 | +128.1% | +224.6% | +499.4% | +6189.9% | |
| $161.30M | +56.3% | +234.2% | +588.8% | +10000.0% | ||
| Annual Net Income | $204.83M | +129.7% | +246.3% | +736.8% | +10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $167.85M | at high | |
| 5Y | $167.85M | at high | |
| All | $167.85M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$116.14M | N/A | +244.5% |
| 5Y | -$116.14M | +244.5% | |
| All | -$116.14M | +244.5% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $167.85M | +52.7% | |
| $109.94M | +219.2% | |
| -$92.22M | +20.6% | |
| -$116.14M | -77.3% | |
| -$65.51M | -110.3% |
| Year | Value | Change |
|---|---|---|
| -$31.15M | -47.6% | |
| -$21.11M | -79.3% | |
| -$11.78M | -147.9% | |
| -$4.75M | -316.2% | |
| -$1.14M | - |
FAQ
- What is the current annual EBITDA of KRYS?
- As of today, KRYS annual EBITDA is $167.85M
- What is 1-year change in KRYS annual EBITDA?
- KRYS annual EBITDA is up +52.67% year-over-year
- What is 3-year change in KRYS annual EBITDA?
- KRYS annual EBITDA is up +244.52% over the past 3 years
- How far is KRYS annual EBITDA from its all-time high?
- KRYS annual EBITDA is currently at its all-time high
- How does KRYS annual EBITDA rank versus sector peers?
- KRYS annual EBITDA is higher than 85.76% of companies in Healthcare sector
- When is KRYS next annual earnings release?
- As of today, the next annual earnings release for KRYS has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$55.42M$9.38M+20.38%
Summary
- Current Value
- As of today, KRYS quarterly EBITDA is $55.42M, up +20.38% on
- Historical Performance
- KRYS quarterly EBITDA is up +46.56% year-over-year, up +257.33% over the past 3 years
- All-Time High Comparison
- KRYS quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- KRYS quarterly EBITDA is +250.39% above its 3-year low of -$36.85M reached on an earlier date
- Sector Comparison
- KRYS quarterly EBITDA is higher than 86.06% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $55.42M | +20.4% | +46.6% | +257.3% | +501.1% | |
| Annual EBITDA | $167.85M | – | +52.7% | +244.5% | +638.9% | |
| TTM EBITDA | $185.28M | +10.5% | +32.1% | +245.7% | +568.0% | |
| Price | $324.77 | +13.2% | +140.7% | +161.5% | +473.2% | |
| PE Ratio | 43.41 | +13.2% | +58.1% | – | – | |
| Quarterly Revenue | $116.36M | +8.6% | +31.9% | +100.0% | +100.0% | |
| Quarterly EPS | $1.83 | +7.9% | +53.3% | +204.1% | +346.4% | |
| $53.69M | +21.3% | +48.4% | +247.8% | +474.1% | ||
| Quarterly Net Income | $55.93M | +8.8% | +56.5% | +223.5% | +453.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $55.42M | at high | |
| 3Y | $55.42M | at high | |
| 5Y | $55.42M | at high | |
| All | $55.42M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $40.85M | N/A | +35.6% |
| 3Y | -$36.85M | N/A | +250.4% |
| 5Y | -$36.85M | +250.4% | |
| All | -$36.85M | +250.4% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of KRYS?
- As of today, KRYS quarterly EBITDA is $55.42M
- What is KRYS quarterly EBITDA most recent change?
- KRYS quarterly EBITDA was up +20.38% on March 31, 2026
- What is 1-year change in KRYS quarterly EBITDA?
- KRYS quarterly EBITDA is up +46.56% year-over-year
- How far is KRYS quarterly EBITDA from its all-time high?
- KRYS quarterly EBITDA is currently at its all-time high
- How does KRYS quarterly EBITDA rank versus sector peers?
- KRYS quarterly EBITDA is higher than 86.06% of companies in Healthcare sector
- When is KRYS next earnings release?
- As of today, the next earnings release for KRYS has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$185.28M$17.60M+10.50%
Summary
- Current Value
- As of today, KRYS TTM EBITDA is $185.28M, up +10.50% on
- Historical Performance
- KRYS TTM EBITDA is up +32.11% year-over-year, up +245.71% over the past 3 years
- All-Time High Comparison
- KRYS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- KRYS TTM EBITDA is +236.01% above its 3-year low of -$136.23M reached on an earlier date
- Sector Comparison
- KRYS TTM EBITDA is higher than 85.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $185.28M | +10.5% | +32.1% | +245.7% | +568.0% | |
| Annual EBITDA | $167.85M | – | +52.7% | +244.5% | +638.9% | |
| Quarterly EBITDA | $55.42M | +20.4% | +46.6% | +257.3% | +501.1% | |
| Price | $324.77 | +13.2% | +140.7% | +161.5% | +473.2% | |
| PE Ratio | 43.41 | +13.2% | +58.1% | – | – | |
| TTM Revenue | $417.30M | +7.2% | +25.1% | +100.0% | +100.0% | |
| TTM EPS | $7.48 | +9.3% | +80.2% | +241.8% | +451.1% | |
| $178.64M | +10.9% | +33.8% | +236.1% | +531.4% | ||
| TTM Net Income | $225.03M | +9.9% | +81.5% | +266.3% | +627.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $185.28M | at high | |
| 3Y | $185.28M | at high | |
| 5Y | $185.28M | at high | |
| All | $185.28M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $158.05M | N/A | +17.2% |
| 3Y | -$136.23M | N/A | +236.0% |
| 5Y | -$136.23M | +236.0% | |
| All | -$136.23M | +236.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of KRYS?
- As of today, KRYS TTM EBITDA is $185.28M
- What is KRYS TTM EBITDA most recent change?
- KRYS TTM EBITDA was up +10.50% on March 31, 2026
- What is 1-year change in KRYS TTM EBITDA?
- KRYS TTM EBITDA is up +32.11% year-over-year
- How far is KRYS TTM EBITDA from its all-time high?
- KRYS TTM EBITDA is currently at its all-time high
- How does KRYS TTM EBITDA rank versus sector peers?
- KRYS TTM EBITDA is higher than 85.78% of companies in Healthcare sector
- When is KRYS next earnings release?
- As of today, the next earnings release for KRYS has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- KRYS Official Website www.krystalbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1711279/000171127926000016/0001711279-26-000016-index.htm
- KRYS Profile on Yahoo Finance finance.yahoo.com/quote/KRYS
- KRYS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/krys
